Evidence map›Paper›PMID 36071157›Full record

ArticleNature2022

Identification of trypsin-degrading commensals in the large intestine.

Youxian Li, Eiichiro Watanabe, Yusuke Kawashima, Damian R Plichta, Zhujun Wang, Makoto Ujike, Qi Yan Ang, Runrun Wu, Munehiro Furuichi, Kozue Takeshita and 22 more

Open access · hybridAbstract read
In one paragraph

Article in Nature, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 1 pooled it
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 1 synthesis or guideline pooled it, 96 citations in OpenAlex.

  1. Pooled it
  2. Diabetes-associatedMicrobiology spectrum · 2026
    Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Engineering Microbial Particles for Next-Generation Biomedical Platforms.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  8. Article
  9. Isolation and Mechanistic Characterization ofFoods (Basel, Switzerland) · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Proteases in intestinal health and disease.Nature reviews. Gastroenterology & hepatology · 2026
    Review
  17. Article
  18. Article
  19. Article
  20. Review

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 11 institutions in 3 countries.

Youxian Li *RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Eiichiro Watanabe *RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.ORCID http://orcid.org/0000-0003-2050-3740
Yusuke Kawashima *RIKEN Center for Integrative Medical Sciences, Yokohama, Japan.ORCID http://orcid.org/0000-0002-9779-8199
Damian R PlichtaInfectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-6555-2557
Zhujun WangRIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Makoto UjikeFaculty of Veterinary Medicine, Nippon Veterinary and Life Science University, Tokyo, Japan.ORCID http://orcid.org/0000-0002-7145-7126
Qi Yan AngInfectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.ORCID http://orcid.org/0000-0002-9788-1283
Runrun WuInterdisciplinary Life Science-PULSe, Purdue University, West Lafayette, IN, USA.
Munehiro FuruichiDepartment of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan.ORCID http://orcid.org/0000-0001-7742-1135
Kozue TakeshitaDepartment of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan.
Koji YoshidaDepartment of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan.ORCID http://orcid.org/0000-0002-0466-8994
Keita NishiyamaDepartment of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan.
Sean M KearneyDepartment of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan.
Wataru SudaRIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Masahira HattoriRIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Satoshi SasajimaDepartment of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan.
Takahiro MatsunagaRIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Xiaoxi ZhangRIKEN Center for Integrative Medical Sciences, Yokohama, Japan.
Kazuto WatanabeJSR-Keio University Medical and Chemical Innovation Center, Keio University School of Medicine, Tokyo, Japan.
Jun FujishiroDepartment of Pediatric Surgery, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
Jason M NormanVedanta Biosciences, Cambridge, MA, USA.ORCID http://orcid.org/0000-0001-5049-8415
Bernat OlleVedanta Biosciences, Cambridge, MA, USA.
Shutoku MatsuyamaDepartment of Virology III, National Institute of Infectious Diseases, Tokyo, Japan.
Ho NamkoongDepartment of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan.
Yoshifumi UwaminoDepartment of Laboratory Medicine, Keio University School of Medicine, Tokyo, Japan.
Makoto IshiiDivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
Koichi FukunagaDivision of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.
Naoki HasegawaDepartment of Infectious Diseases, Keio University School of Medicine, Tokyo, Japan.ORCID http://orcid.org/0000-0003-0717-7450
Osamu OharaRIKEN Center for Integrative Medical Sciences, Yokohama, Japan.ORCID http://orcid.org/0000-0002-3328-9571
Ramnik J XavierInfectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA. xavier@molbio.mgh.harvard.edu.ORCID http://orcid.org/0000-0002-5630-5167
Koji AtarashiRIKEN Center for Integrative Medical Sciences, Yokohama, Japan. kojiatarashi@keio.jp.ORCID http://orcid.org/0000-0001-5422-0736
Kenya HondaRIKEN Center for Integrative Medical Sciences, Yokohama, Japan. kenya@keio.jp.ORCID http://orcid.org/0000-0001-8937-9835
Keio University · JPBroad Institute · USKazusa DNA Research Institute · JPRIKEN Center for Integrative Medical Sciences · JPVedantra Pharmaceuticals (United States) · USNational Institute of Infectious Diseases · JPNippon Veterinary and Life Science University · JPPurdue University West Lafayette · USThe University of Tokyo · JPUniversity of Oslo · NOWaseda University · JP

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 1991 to 2026
$35.3M
Identification and characterization of gut microbial bioactive molecules that determine predisposition to autoimmune disease and atopyR01AT009708 · NCCIH · HARVARD MEDICAL SCHOOL · PI CLARDY, JON, XAVIER, RAMNIK J · 2017 to 2021
$3.3M
NCCIH NIH HHS R01 AT009708NIDDK NIH HHS P30 DK043351
6 · The paper itself

Abstract

Increased levels of proteases, such as trypsin, in the distal intestine have been implicated in intestinal pathological conditions

Indexed as

Gastrointestinal MicrobiomeIntestine, LargeSymbiosisTrypsinAdministration, OralAnimalsBacterial Secretion SystemsBacterial VaccinesBacteroidetesCitrobacter rodentiumCOVID-19DiarrheaFecesHumansImmunoglobulin AMiceBacterial Secretion SystemsBacterial VaccinesImmunoglobulin ATrypsin

Identifiers

PMID36071157
PMCPMC9477747
OpenAlexW4294904666

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.